Companies
Explore all the available companies. Are you wondering how to find wonderful businesses at great price? Start from A... or take a look at Compoundeer Ranking.
Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.
ACXPAcushnet Holdings Corp.
Acushnet Holdings Corp is a US-based company engaged in the design, development, manufacture, and distribution of golf products. Its product category includes golf balls, golf shoes, golf clubs, wedges, putters, golf gloves, golf gear and golf wear, of which key revenue is derived from the sales of golf balls and golf gloves. The operating segments of the company are Titleist golf balls, Titleist golf clubs, Titleist golf gear and FootJoy golf wear. The company operates in the United States, EMEA, Japan, Korea and other countries, of which a majority of the revenue is generated from the operations in the United States.
GOLFAcutus Medical, Inc.
Acutus Medical Inc is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. The company designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes Novel access sheaths, Transseptal crossing tools, Diagnostic and mapping catheters, Ablation catheters, Mapping and imaging consoles and accessories, as well as Supporting algorithms and Software programs. It markets and sells its electrophysiology products worldwide to hospitals and electrophysiologists that treat patients with arrhythmias. It has a business presence in the United States and Europe.
AFIBAcv Auctions Inc.
ACV Auctions Inc is a mobile platform for wholesale car auctions. It provides a digital marketplace for wholesale vehicle transactions and data services that offer transparent and accurate vehicle information for customers.
ACVAAdagene Inc.
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.
ADAGAdagio Medical Holdings, Inc.
Adagio Medical, Inc., is a medical device company located in Laguna Hills, California. Co-founded in 2011 by Dr. James Cox, the inventor of gold standard Cox-Maze procedure, and Olav Bergheim, a serial entrepreneur, Adagio Medical is developing innovative ablation technologies for the treatment of cardiac arrhythmias including atrial fibrillation, atrial flutter, and ventricular tachycardia. Adagios unique portfolio is based on Ultra-Low Temperature Cryoablation (ULTC) and Pulsed-Field Cryoablation (PFCA) designed to produce durable, contiguous, transmural lesions anywhere in the heart.
ADGMAdamas One Corp.
Adamas One Corp., a diamond company, produces single crystal diamonds and diamond materials for diamond jewelry industry and industrial markets in the United States and internationally. The company was incorporated in 2018 and is based in Scottsdale, Arizona.
JEWLAdams Diversified Equity Fund, Inc.
Adams Diversified Equity Fund Inc is a diversified investment company. Its investment objectives is preservation of capital the attainment of reasonable income from investments and an opportunity for capital appreciation.
ADXAdams Natural Resources Fund, Inc.
Adams Natural Resources Fund Inc is a closedend equity investment company. The investment objectives of the fund are the preservation of capital the attainment of reasonable income from investments and an opportunity for capital appreciation.
PEOAdams Resources & Energy, Inc.
Adams Resources & Energy Inc is mainly engaged in the business of crude oil marketing, tank truck transportation of liquid chemicals and dry bulk, and oil and gas exploration and production. The company operates through three business segments namely, crude oil marketing, which involves the sale and delivery of crude oil purchased either directly from producers or from others on the open market; Transportation, which transports liquid chemicals, pressurized gases, asphalt and dry bulk on a for hire basis throughout the continental U.S., and into Canada and Mexico; and Pipeline and Storage Segment. Substantial revenue comes from crude oil marketing.
AEAdapthealth Corp.
AdaptHealth Corp is a provider of home healthcare equipment and related services. Its products portfolio includes Mobility Products, Sleep Therapy and Sleep Therapy Supplies, Respiratory Therapy, Non-invasive Ventilation, Nutrition Supplies, Bed Lifts, Seat Lift Chairs, Home Modifications, Power Mobility, and Bath Aids.
AHCOAdaptimmune Therapeutics Plc
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A10 T-cell therapy, NON-SMALL CELL LUNG CANCER, AFP SPEAR T-cell, MAGE-A4 SPEAR T-cell therapy and NY-ESO SPEAR T-cell for multiple cancer types.
ADAPAdaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
ADPTAdastra Holdings Ltd.
Adastra Holdings Ltd is an extraction and processing solutions company. It aims to develop and deploy large-scale cannabis and hemp extraction technologies and provide turnkey processing solutions to help licensed standard and micro-cultivators maximize the value of every harvest.
XTXXFAdc Therapeutics Sa
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.
ADCTAddentax Group Corp.
Addentax Group Corp is an investment holding company. The company's operating segment includes Garment manufacturing; Logistics services; Epidemic prevention supplies; Property management and subleasing and Corporate and other. It generates maximum revenue from the Logistics services segment. The Logistics services segment provides logistic services. Geographically, it derives a majority of its revenue from China.
ATXGAddex Therapeutics Ltd.
Addex Therapeutics Ltd is a biopharmaceutical company. The company operates through single segment which includes developing drugs to improve human health. It is focused on the development of novel, orally available, small molecule allosteric modulators for neurological disorders. In addition, it is also engaged in the development of the dipraglurant and ADX71441 program. The company's geographical area of operations includes Switzerland and Europe.
ADXNAddus Homecare Corp
Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the following segments: Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.
ADUSAddvantage Technologies Group Inc
Addvantage Technologies Group Inc is a communications infrastructure services and equipment provider operating a diversified group of companies through its Wireless Infrastructure Services and Telecommunications segments. Its Wireless Infrastructure Services segment provides turn-key wireless services including the installation, modification and upgrading of equipment on communication towers and small cell sites for wireless carriers, national integrators, tower owners and major equipment manufacturers. Its Telecommunications segment sell equipment used to acquire, distribute, and protect the communications signals. The Telecommunications segment generates maximum revenue for the company.
AEYGQAdecoagro S.a.
Adecoagro SA is a Luxembourg-based agricultural company. It is involved in the wide range of businesses, including farming crops and other agricultural products, dairy operations, sugar, ethanol, and energy production and land transformation. The company operates through three segments namely Farming, Sugar, Ethanol and Energy, and Land Transformation. The Farming segment consists of planting, harvesting, and sale of grains, oilseeds and fibers, rice and production and sale of dairy products; the Sugar, Ethanol and Energy segment consists of cultivating sugar cane which is processed in owned sugar mills, transformed into ethanol; and the Land Transformation segment comprises identification and acquisition of underdeveloped and undermanaged farmland.
AGROAdeia Inc.
Xperi Holding Corp is a consumer and entertainment product/solutions licensing company. It operates in two segments: Intellectual Property Licensing (IP) and Product. In the IP segment, it primarily license innovations to leading companies in the broader entertainment industry, and those developing new technologies that will help drive this industry forward. Product segment creates extraordinary experiences at home and on the go for millions of consumers around the world, elevating content and how audiences connect with it in a way that is more intelligent, immersive, and personal. It includes Pay-TV, Consumer Electronics, Connected Car, and Media Platform. The company's geographical segments include the United States, Japan, South Korea, Europe, the Middle East, and Others.
ADEAAdhera Therapeutics, Inc.
Adhera Therapeutics Inc is an emerging specialty biotech company that is strategically evaluating its focus including a return to a drug discovery and development company.
ATRXAdia Nutrition, Inc.
ADIA Nutrition Inc, (ADIA) a public company dedicated to revolutionizing healthcare through innovative partnerships. Our primary focus is to work closely with healthcare providers and health insurance companies to facilitate and provide Autologous Hematopoietic Stem Cell Transplantation (AHSCT) treatments for Multiple Sclerosis (MS) patients. ADIA envisions a future where AHSCT is a widely accessible and transformative treatment option for MS patients. Through our commitment to collaboration, advocacy, and quality care, we aim to redefine the standard of treatment for MS and contribute to improved outcomes and quality of life for those affected by the disease. Follow us on this journey as we transcend traditional healthcare boundaries and empower MS patients to embrace a future filled with hope and possibilities. At ADIA, we believe in transcending limitations for a healthier and more vibrant tomorrow.
ADIAAdial Pharmaceuticals, Inc.
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder.
ADILAdicet Bio, Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. The company is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.
ACETAdient Plc
Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment into this new company. Adient is the leading seating supplier to the industry with about one third of the global market. Its share in China is now nearly 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated seating revenue from joint ventures after factoring in the sale was around $4.5 billion in fiscal 2021 and guidance for consolidated China revenue after the deal (before new China COVID-19 lockdowns in Spring 2022) was slightly over $1 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2021 consolidated revenue, excluding joint venture sales, was $13.7 billion.
ADNTAditxt, Inc.
Aditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantation procedures as these drugs prevent or delay organ rejection. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) which utilizes tolerogenic approach that utilizes the body's natural process of cell death, to deliver a modified antigen that signals the immune system to become tolerant to transplanted tissues.
ADTXAdlai Nortye Ltd.
Adlai Nortye Ltd is a global clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The Company's pipeline includes three clinical-stage drug candidates, buparlisib (AN2025), palupiprant (AN0025), and AN4005, as well as three preclinical candidates. AN2025 is a pan-phosphoinositide 3-kinase (PI3K) inhibitor that is designed to act against solid tumors. AN2025 is undergoing Phase III, open-label clinical trial for the treatment of recurrent or metastatic head and neck squamous cell carcinomas (HNSCC) after anti-programmed death-1 (PD-1) or its ligand (PD-L1) treatment. AN0025 is a small molecule prostaglandin E receptor 4 (EP4) antagonist. AN4005 is an internally discovered oral small molecule PD-L1 inhibitor in development to induce and stabilize PD-L1 dimerization and thereby disrupt the interaction between PD-1 and PD-L1. Its preclinical candidates include: AN8025, AN1025, and AN9025.
ANLAdm Endeavors, Inc.
ADM Endeavors Inc operates a diverse vertical integrated business in the Dallas/Fort Worth area, consisting of a retail sales division, screenprint production, embroidery production, digital production, import wholesale sourcing, and uniforms. It generates revenues from Promotional sales followed by School uniform sales.
ADMQAdm Tronics Unlimited, Inc.
ADM Tronics Unlimited Inc is a diversified, technology-based developer and manufacturer of technologies and products in the United States. The company's operating segment includes Chemical; Electronics and Engineering. It generates maximum revenue from Electronics segment. The Electronics segment develops and manufactures electronic technologies for non-invasive, electrotherapeutic and diagnostic medical devices as well as for veterinary and other applications. It derives revenue from the production and sale of electronics for medical devices and other applications; environmentally safe chemical products for industrial, medical and cosmetic uses; research, development, regulatory, and engineering services.
ADMT